NCT07464756 2026-03-11
SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting
Clinical Trials
13 trialsNCT05753306 2026-02-25
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study
Mayo Clinic
Phase 2 Recruiting
NCT07263386 2025-12-04
ARTEMIS-GC3
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
NCT05709574 2025-10-16
Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer
University of Arizona
Phase 2 Recruiting
NCT07178808 2025-09-17
PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER
Banner Health
Phase 2 Recruiting
NCT04164979 2025-08-11
Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma
University of California, Irvine
Phase 2 Active not recruiting
NCT06888037 2025-03-21
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
Ruijin Hospital
Phase 2 Not yet recruiting
NCT04162665 2025-01-09
Pre-operative Adaptive Short Court Radiation Therapy in Gastric Cancer
Washington University School of Medicine
Phase 2 Terminated
NCT05034887 2024-11-19
Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients with HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma
National Cancer Center Hospital East
Phase 2 Recruiting
NCT06667050 2024-10-31
CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
West China Hospital
Phase 2 Active not recruiting
NCT06496789 2024-07-11
Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT05235906 2023-08-09
A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT05705635 2023-01-31
A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown